tration for the life-span might result in renal papilla/pelvis lesions. In a separate study, early proliferative response of the renal papilla/pelvis epithelia was assessed in rats given BBN or another bladder carcinogen EHBN for 4 weeks.
EFFECT OF BLADDER CARCINOGEN ON RAT KIDNEY

Materials and Methods
Test chemicals BBN (Izumi Chemical Co. , Yokohama) and EHBN (provided by courtesy of Dr M. Okada, Tokyo Biochemical Research Institute, Tokyo) were used as bladder carcinogens.
Animals
A total of 185 male 6 week-old F344 rats (Charles River Japan, Inc. , Atsugi) were used. They were housed in polycarbonate cages on hardwood chip bedding in an environmentcontrolled room, maintained at 22, =2'C and 60+ 10% relative humidity and artificially illuminated for 12 hrs each day.
Experimental procedure Two year carcinogenici4y SI"dy. The aniin als were randomly allocated to 4 treated and I control group comprising 30 or 50 rats each. All animals were given pellet basal diet (Oriental M, Oriental Yeast Co. , Tokyo). BBN was administeted at dosage levels of 50,10,5, or I ppm in the drinking water. Since BBN is sensitive to fluorescent light, light opaque drinking bottles were used for its administration. After 1/2 weeks, all surviving animals were killed by exsanguination under ether anesthesia and a gross pathological examination made during necropsy. Most of the organs or tissues. and all gross lesions taken were fixed in 10% phosphate-buffered formalin and processed for histopathological assessment (sections stained with hematoxylin and eosin). The kidneys (pelvis and papilla) were examined in particular detail. Tissues from animals that died or became moribund during the experiment were also examined histopathologicalIy.
Four-week study of proliferation in the renal pelvic epithelium. Ten rats were divided into two groups of 5 rats each and given BBN or EHBN at a dose of 500 ppm in the drinking water for 4 weeks when they and 5 control animals were injected ip. with 100 ing/kg body weight of 5-brom0-2'-deoxyuridine (BrdU)(Sigma Chemical Co. , MO, USA). Circadian rhythms have been demonstrated in a number of different cell cycle components and therefore, in order to avoid any variance from this source, the animals were sequentially killed so that one rat from each group was simultaneously killed by exsanguination Ih after BrdU injection, this being repeated until all had been processed. The kidneys were quickly removed and weighed, fixed in 10% phosphate buffered formalin, and sections routinely prepared for histopathological examination and for jinin unohistochemical BrdU staining (Vectastain Elite ABC Kit, Vector Laboratories, Inc. , CA, USA). The numbers of cells incorporating BrdU into DNA as a propotion of all epithelial cells of the renal pelvis or papilla were counted and labeling indices expressed as percentage values.
Slamttc@I on@!ysis
The significances of differences between the means of treated and control groups in body and organ weights or DNA synthesis levels were analysed using the two-tailed Student's t-test.
Insufficient homogeneity of variance was corrected with respect to the degrees of feedom according to the method of WeIch.
Results
Two-year carcinogenici4y study General. Data for cumulative mortality of rats given 0 50 ppm BBN in the drinking water are shown in Table I . The first bladder tumor was found on the death of a rat given 50 ppm in week 52. All animals receiving this high dose died from bladder cancers by week 91 . Average survival rats for each group were as follows : 50 ppm, 78, =8 : 10 ppm, 105, =13 : 5 ppm, 108, =8 : I ppm, 109^9 : 0 ppm, 108, =10 weeks.
Body weight curves are illustrated in Fig. I . Average body weights of all groups, with the exception of the 50 ppm group, were coinparable throughout the experiment. Significantly reduced ( 3) 2 ( 7) 5 ( 17) 16 ( 53) 23 ( 77) 29 ( 97) 30 (100) 30 (100) 30 (100) 30 ( I ( 3) I ( 3) 3 (10) 4 (13) 6 (20) 7 (23) 8 (27) 11 (37) 14 ( ( 3) 2 ( 7) 3 (10) 4 (13) 7 (23) 7 (23) 10 ( ( 3) 3 (10) 3 (10) 4 (13) 5 (17) 6 (20) 7 (23) 9 ( ( 4) 2 ( 4) 2 ( 4) 3 ( 6) 4 ( 8) 7 (14) 9 (18) 10 (20) 15 (30) 22 (44) 10 f weight gain was observed in the 50 ppm group from week 68. Final body and kidney weights are presented in Table 2 . Final body weights in all groups given BBN tended to be decreased. Both absolute and relative weights of the kidneys in groups given BBN were similar to control group values. Since all rats given 50 ppm of BBN died, the respective data were lacking. Histop@Ihology. Findings for neoplastic changes including renal proliferative lesions are presented in Table 3 . Tumors of the urinary bladder were induced by BBN even at the low dose of I ppm as previously publised". In contrast, no tumors were found in the kidneys of any rat given BBN. Epithelial hyperPIasia of transitional cells in the renal papilla pelvis was sporadically observed for a small number of animals in the BBNtreated groups. Atypical tubules were observed in only one 50 ppm group case. Although incidences of malignant lymphoma leukemia or tumors of the pituitary, thyroid, adrenal, and testis were significantly lower in the 50 ppm group than in the control group, this was considered to be due to early death. A significant increase or trend in . 96 112 hyper plastic nodule in the I ppm or 5 ppm groups, but since no elevation of this lesion development was found in the 10 ppm group (body weights in this group were similar to these of the 5 ppm group), the findings were considered to be incidental. Incidences of neoplastic lesions in the other organs in groups given BBN were coinparable to control group values.
Cell prol;for@tio" study Final body and kidney weights, and labeling indices for the renal papilIa/pelvis are presented in Table 5 . Final body weights were significantly decreased in the BBN group as compared to control values. There were no differences in the kidney weights between treated and control groups. In addition, the labeling indices of the renal papilla and pelvis epithelial cells were not treated with BBN or increased in the groups EHBN.
Kidney (%)
Simple hyper PIasia (97) 23 (77) 7 (23) 2 ( 7) o
Discussion
The current inventigation clearly demonstrated that administration of the bladder carcinogen BBN, even for the life-span, does not cause tumors of the renal papilla/pelvis in rats, despite its lining by transitional epithelium shared by the urinary bladder. In addition, no carcinogenic potential for any other organs was exerted in the BBNtreated animals. The additional experiment also Recently it has been reported that BBN induces renal pelvic tumors when administered to NON/Shi mouse strain or SD-C rat strain which suffer from hereditary hydronephrosis".".
Furthermore, it is well documented that uracil calculi formation astreatment induces urinary SOCiated with papillomatosis of both urinary bladder and renal pelvis in rats22.23 as well as causing hydronephrosis". Concomitant treatment with BBN and uracil induces not only bladder carcinomas but also renal pelvic carcinomas". The hydronephrosis caused by uracil results in urine stasis, and the renal papilla/pelvic mucosa may therefore be exposed to urine for far longer than normal. It was earlier reported that partial cystectomy significantly inhibits the development of preneoplastic lesions of the bladder in rats pretreated with BBN26. The results indicate that the reduced cubic volume of the bladder and resultant continuous micturition mean that the bladder mucosa is only exposed to urine for a short time.
Under normal conditions, urine exposure (involving the ultimate carcinogen) of the renal papilla/pelvic mucosa is very short. Thus, urine stasis in target organs might be a crucial factor for BBN carcinogenesis. 
